Following a vote by the Maryland House of Delegates, the state now has all the pieces in place to proceed with plans for a so-called ‘Prescription Drug Affordability Board,’ a controversial tactic for controlling the rising cost of medicines.

The House voted 95-to-38 to override a veto issued last year by Gov. Larry Hogan, who objected to the board, which is designed to function like rate-setting boards that regulate what public utilities can charge residents. Last month, the Senate also overrode the veto, which Hogan issued over concerns the move would raise taxes and fees at a time when the Covid-19 pandemic had already hurt citizens.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What’s included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Source: STATNEWS.COM

Leave a Reply

ArabicChinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

[mc4wp_form id="449"]